Validation of a novel molecular diagnostic panel for pediatric musculoskeletal infections: Integration of the Cepheid Xpert MRSA/SA SSTI and laboratory-developed real-time PCR assays for clindamycin resistance genes and Kingella kingae detection - PubMed (original) (raw)
Validation of a novel molecular diagnostic panel for pediatric musculoskeletal infections: Integration of the Cepheid Xpert MRSA/SA SSTI and laboratory-developed real-time PCR assays for clindamycin resistance genes and Kingella kingae detection
Justin B Searns et al. J Microbiol Methods. 2019 Jan.
Abstract
Background: Pathogen detection in pediatric patients with musculoskeletal infections relies on conventional bacterial culture, which is slow and can delay antimicrobial optimization. The ability to rapidly identify causative agents and antimicrobial resistance genes in these infections may improve clinical care.
Methods: Convenience specimens from bone and joint samples submitted for culture to Children's Hospital Colorado (CHCO) from June 2012 to October 2016 were evaluated using a "Musculoskeletal Diagnostic Panel" (MDP) consisting of the Xpert MRSA/SA SSTI real-time PCR (qPCR, Cepheid) and laboratory-developed qPCRs for Kingella kingae detection and erm genes A, B, and C which confer clindamycin resistance. Results from the MDP were compared to culture and antimicrobial susceptibility testing (AST) results.
Results: A total of 184 source specimens from 125 patients were tested. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the Xpert MRSA/SA SSTI compared to culture and AST results were 85%, 98%, 93%, and 95% respectively for MSSA and 82%, 100%, 100%, and 99% for MRSA. Compared to phenotypic clindamycin resistance in S. aureus isolates, the erm A, B, and C gene PCRs collectively demonstrated a sensitivity, specificity, PPV, and NPV of 80%, 96%, 67%, and 98%. In comparison to clinical truth, Kingella PCR had a sensitivity, specificity, PPV, and NPV of 100%, 99.5%, 100%, and 100%.
Conclusions: This novel MDP offers a rapid, sensitive, and specific option for pathogen detection in pediatric patients with musculoskeletal infections.
Keywords: Diagnostics; Infection; Osteomyelitis; Pediatric; Septic arthritis.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
- A New Highly Sensitive and Specific Real-Time PCR Assay Targeting the Malate Dehydrogenase Gene of Kingella kingae and Application to 201 Pediatric Clinical Specimens.
El Houmami N, Durand GA, Bzdrenga J, Darmon A, Minodier P, Seligmann H, Raoult D, Fournier PE. El Houmami N, et al. J Clin Microbiol. 2018 Jul 26;56(8):e00505-18. doi: 10.1128/JCM.00505-18. Print 2018 Aug. J Clin Microbiol. 2018. PMID: 29875189 Free PMC article. - The rtxA toxin gene of Kingella kingae: a pertinent target for molecular diagnosis of osteoarticular infections.
Lehours P, Freydière AM, Richer O, Burucoa C, Boisset S, Lanotte P, Prère MF, Ferroni A, Lafuente C, Vandenesch F, Mégraud F, Ménard A. Lehours P, et al. J Clin Microbiol. 2011 Apr;49(4):1245-50. doi: 10.1128/JCM.01657-10. Epub 2011 Jan 19. J Clin Microbiol. 2011. PMID: 21248099 Free PMC article. - First report of Kingella kingae diagnosed in pediatric bone and joint infections in Morocco.
Moutaouakkil K, Oumokhtar B, Abdellaoui H, El Fakir S, Arhoune B, Mahmoud M, Atarraf K, Afifi MA. Moutaouakkil K, et al. BMC Infect Dis. 2021 Jul 20;21(1):697. doi: 10.1186/s12879-021-06361-8. BMC Infect Dis. 2021. PMID: 34284735 Free PMC article. - Kingella kingae infections in paediatric patients: 5 cases of septic arthritis, osteomyelitis and bacteraemia.
Birgisson H, Steingrimsson O, Gudnason T. Birgisson H, et al. Scand J Infect Dis. 1997;29(5):495-8. doi: 10.3109/00365549709011861. Scand J Infect Dis. 1997. PMID: 9435039 Review. - Kingella kingae infections of the skeletal system in children: diagnosis and therapy.
Yagupsky P. Yagupsky P. Expert Rev Anti Infect Ther. 2004 Oct;2(5):787-94. doi: 10.1586/14789072.2.5.787. Expert Rev Anti Infect Ther. 2004. PMID: 15482240 Review.
Cited by
- Delaying antimicrobials for pediatric bone and joint infections: Balancing clinical risks with diagnostic benefits.
Searns JB. Searns JB. Front Pediatr. 2022 Oct 31;10:975221. doi: 10.3389/fped.2022.975221. eCollection 2022. Front Pediatr. 2022. PMID: 36389360 Free PMC article. No abstract available. - Clinical Relevance of Xpert MRSA/SA in Guiding Therapeutic Decisions for Staphylococcal Infections: A Diagnostic Test Accuracy Analysis.
Ojha SC, Chen K, Sun C, Ahmed S, Sheng YJ, Deng CL. Ojha SC, et al. Infect Dis Ther. 2022 Jun;11(3):1205-1227. doi: 10.1007/s40121-022-00632-w. Epub 2022 Apr 22. Infect Dis Ther. 2022. PMID: 35451743 Free PMC article. - Molecular Tools for Guiding Therapy in Patients With Staphylococcal Bone and Joint Infections: A Diagnostic Test Accuracy Meta-analysis.
Chen K, Wang Y, Yuan Y, Qin W, Sheng YJ, Ahmed S, Sun C, Deng CL, Ojha SC. Chen K, et al. Front Endocrinol (Lausanne). 2022 Jul 13;13:792679. doi: 10.3389/fendo.2022.792679. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909576 Free PMC article. - Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management.
McNeil JC. McNeil JC. Infect Drug Resist. 2020 Dec 14;13:4459-4473. doi: 10.2147/IDR.S257517. eCollection 2020. Infect Drug Resist. 2020. PMID: 33364793 Free PMC article. Review. - Broad-range 16 s rDNA PCR in synovial fluid does not improve the diagnostic performance of septic arthritis in native joints in adults: cross-sectional single-center study in 95 patients.
Coiffier G, David C, Gauthier P, Le Bars H, Guggenbuhl P, Jolivet-Gougeon A, Albert JD. Coiffier G, et al. Clin Rheumatol. 2019 Jul;38(7):1985-1992. doi: 10.1007/s10067-019-04492-7. Epub 2019 Mar 8. Clin Rheumatol. 2019. PMID: 30850963
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical